Upon BRAFV600E induction in the stem-cell population (K5/K14+), cells rapidly activated the MAPK signalling pathway without the need for further promotion (Supplementary Fig. 2b), resulting in fast-growing tumours (9 and 10 days to tumour onset) (Fig. 2c, d). The gene discussed is KRT5; the disease is neoplasm.